Cabozantinib for Late Stage Kidney Cancer

Cometriq (cabozantinib) is already approved for thyroid cancer and is showing promise for late stage kidney cancer. GRACEcast 259 Kidney Author: cancergrace Added: 08/13/2014
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts